地中海饮食与低脂饮食对心血管疾病长期二级预防(CORDIOPREV):一项随机对照试验
CORDIOPREV 研究为单中心随机临床试验,纳入 1002 例 20–75 岁已确诊冠心病患者,按 1:1 随机接受地中海饮食或低脂饮食干预,随访 7 年。主要终点为主要心血管事件复合终点(心肌梗死、血运重建、缺血性卒中、外周动脉疾病、心血管死亡)。地中海饮食组主要终点发生 87 例,低脂饮食组 111 例(粗发生率每 1000 人年 28.1 vs 37.7,log-rank p=0.039);多因素校正 HR 范围为 0.719(95%CI 0.541–0.957)至 0.753(95%CI 0.568–0.998),支持地中海饮食。效应在男性中更明显(67/414 vs 94/413,多因素校正 HR 0.669 [95%CI 0.489–0.915],log-rank p=0.013),女性中两组无差异。
要点
- 已确诊冠心病患者随机接受地中海饮食或低脂饮食,随访 7 年,主要心血管事件地中海饮食组 87 例 vs 低脂饮食组 111 例,log-rank p=0.039。
- 多因素校正 HR 范围为 0.719(95%CI 0.541–0.957)至 0.753(95%CI 0.568–0.998),支持地中海饮食。
- 男性中主要终点发生 67/414(16.2%)vs 94/413(22.8%),多因素校正 HR 0.669(95%CI 0.489–0.915),log-rank p=0.013。
- 175 例女性中两组主要终点无差异。
- 作者认为结果支持在二级预防中使用地中海饮食。
适用人群与场景
- 已确诊冠心病、年龄 20–75 岁的患者,来自西班牙科尔多瓦 Reina Sofia 大学医院的单中心随机临床试验。
处置流程与药物剂量
- 由营养师团队实施饮食干预:地中海饮食或低脂饮食,随访 7 年。
研究设计与关键结果
- 研究类型:单中心随机临床试验,2009年10月1日至2012年2月28日共纳入 1002 例患者,低脂饮食组 500 例(49.9%),地中海饮食组 502 例(50.1%);平均年龄 59.5 岁(SD 8.7),男性 827/1002 例(82.5%)。
- 主要终点(心肌梗死、血运重建、缺血性卒中、外周动脉疾病、心血管死亡复合终点)共发生 198 例:地中海饮食组 87 例 vs 低脂饮食组 111 例;粗发生率每 1000 人年 28.1(95%CI 27.9–28.3)vs 37.7(95%CI 37.5–37.9),log-rank p=0.039。
- 多因素校正 HR 范围为 0.719(95%CI 0.541–0.957)至 0.753(95%CI 0.568–0.998),支持地中海饮食。
- 男性亚组:地中海饮食组 67/414 例(16.2%)vs 低脂饮食组 94/413 例(22.8%),多因素校正 HR 0.669(95%CI 0.489–0.915),log-rank p=0.013;175 例女性中两组无差异。
证据类型、等级与局限
- 证据类型:随机对照试验(RCT)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在二级预防中地中海饮食优于低脂饮食预防主要心血管事件,结果与临床实践相关,支持在二级预防中使用地中海饮食。
指南或共识出处
- CORDIOPREV 研究,注册号 ClinicalTrials.gov NCT00924937。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Mediterranean and low-fat diets are effective in the primary prevention of cardiovascular disease. We did a long-term randomised trial to compare the effects of these two diets in secondary prevention of cardiovascular disease.
METHODS: The CORDIOPREV study was a single-centre, randomised clinical trial done at the Reina Sofia University Hospital in Córdoba, Spain. Patients with established coronary heart disease (aged 20-75 years) were randomly assigned in a 1:1 ratio by the Andalusian School of Public Health to receive a Mediterranean diet or a low-fat diet intervention, with a follow-up of 7 years. Clinical investigators (physicians, investigators, and clinical endpoint committee members) were masked to treatment assignment; participants were not. A team of dietitians did the dietary interventions. The primary outcome (assessed by intention to treat) was a composite of major cardiovascular events, including myocardial infarction, revascularisation, ischaemic stroke, peripheral artery disease, and cardiovascular death. This study is registered with ClinicalTrials.gov, NCT00924937.
FINDINGS: From Oct 1, 2009, to Feb 28, 2012, a total of 1002 patients were enrolled, 500 (49·9%) in the low-fat diet group and 502 (50·1%) in the Mediterranean diet group. The mean age was 59·5 years (SD 8·7) and 827 (82·5%) of 1002 patients were men. The primary endpoint occurred in 198 participants: 87 in the Mediterranean diet group and 111 in the low-fat group (crude rate per 1000 person-years: 28·1 [95% CI 27·9-28·3] in the Mediterranean diet group vs 37·7 [37·5-37·9] in the low-fat group, log-rank p=0·039). Multivariable-adjusted hazard ratios (HRs) of the different models ranged from 0·719 (95% CI 0·541-0·957) to 0·753 (0·568-0·998) in favour of the Mediterranean diet. These effects were more evident in men, with primary endpoints occurring in 67 (16·2%) of 414 men in the Mediterranean diet group versus 94 (22·8%) of 413 men in the low-fat diet group (multiadjusted HR 0·669 [95% CI 0·489-0·915], log-rank p=0·013), than in 175 women for whom no difference was found between groups.
INTERPRETATION: In secondary prevention, the Mediterranean diet was superior to the low-fat diet in preventing major cardiovascular events. Our results are relevant to clinical practice, supporting the use of the Mediterranean diet in secondary prevention.
FUNDING: Fundacion Patrimonio Comunal Olivarero; Fundacion Centro para la Excelencia en Investigacion sobre Aceite de Oliva y Salud; local, regional, and national Spanish Governments; European Union.
参考来源
- Delgado-Lista J, Alcala-Diaz JF, Torres-Peña JD, et al. Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial. Lancet. 2022. PMID: 35525255. doi:10.1016/S0140-6736(22)00122-2
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。